Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.

Breast cancer (Tokyo, Japan) - 1 Mar 2024

Chen Bo-Fang, Tsai Yi-Fang, Lien Pei-Ju, Lin Yen-Shu, Feng Chin-Jung, Chen Yen-Jen, Cheng Han-Fang, Liu Chun-Yu, Chao Ta-Chung, Lai Jiun-I, Tseng Ling-Ming, Huang Chi-Cheng

Abstract excerpt

BACKGROUND: The human epidermal growth factor receptor 2 (HER2) negative luminal B1 subtype of breast cancer has been reported with a poorer outcome than luminal A in recent studies. This study aimed to investigate the molecular alterations and identify potential therapeutic targets by analyzing the genetic profiling from a cohort of luminal B1 breast cancer in Taiwan. METHODS: We enrolled patients with luminal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Neoplasm Recurrence, Local

Share to Recurrence

Share to Taiwan

Source

Identifiers

PMID: 38070067
DOI: 10.1007/s12282-023-01524-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.PMID 38070067Read ↗

Prevalent Landscape of Tumor Genomic Alterations of Luminal B1 Breast Cancers Using a Comprehensive Genomic Profiling Assay in TaiwanSemantic proximity Read ↗

Comprehensive genomic profiling of Taiwanese triple-negative breast cancer with a large targeted sequencing panel.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Taiwanese Breast Cancer Using a Novel Targeted Sequencing PanelSemantic proximity Read ↗

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.Semantic proximity Read ↗

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesSemantic proximity Read ↗

Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.Semantic proximity Read ↗

Comprehensive genomic profiling of Taiwanese triple negative breast cancers with medium- and large-sized sequencing panels: a comparative study of actionable genesSemantic proximity Read ↗

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)Semantic proximity Read ↗

Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese PopulationSemantic proximity Read ↗

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.Semantic proximity Read ↗

Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.Semantic proximity Read ↗

Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.